VIGILVESTLibrary
← Library

ZIMMER BIOMET HOLDINGS, INC.

ZBH
SEC CIK 1136869Price charts ↗
Writing the earnings story…

Financials

Revenue+9.3% YoY
$2.09B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income+30.8% YoY
$238.1M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)+34.1% YoY
$1.22
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Quarter endingRevenueNet incomeEPS
Mar 2026$2.09B$238.1M$1.22
Sep 2025$2.00B$230.9M$1.16
Jun 2025$2.08B$152.8M$0.77
Mar 2025$1.91B$182.0M$0.91
Sep 2024$1.82B$249.1M$1.23
Jun 2024$1.94B$242.8M$1.18
Mar 2024$1.89B$172.4M$0.84
Sep 2023$1.75B$162.7M$0.77

Annual revenue

FY21FY22FY23FY24FY25

Source filings

Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.

Glossary

Revenue
Net income
EPS
Gross margin
Net margin
Fiscal year

Hover any underlined term for its definition.